aspartic acid has been researched along with Cancer of Stomach in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 6 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, X; Lu, X; Sun, X; Wang, N; Wang, Q; Wu, D; Yin, H; Yuan, M | 1 |
| Candy Chen, HJ; Hu, SX; Wu, DC; Yang, TC | 1 |
| Han, FH; Hu, H; Huang, J; Luo, ML; Tan, JN; Yang, B; Zhang, W; Zhong, GY; Zhou, SN | 1 |
| Deng, D; Li, S; Pan, C; Ren, J; Shang, D; Wei, T; Wu, Z; Yin, P; Yuan, Q; Zhang, B | 1 |
| Chen, X; Chen, Y; Dai, D; Huang, Y; Jin, W; Lin, W; Teng, L; Wang, H; Wang, W; Yang, Y; Zhang, H; Zhang, J; Zhang, Y | 1 |
| Cheng, X; Du, H; Gan, X; Hu, Y; Li, S; Li, Z; Wang, Y; Xing, X; Yan, Y | 1 |
| Hayashi, R; Kato, N; Katsumata, Y; Kitazawa, K; Ohkoshi, T; Sanada, D; Yamaguchi, S | 1 |
| Hibasami, H; Iwase, H; Takahashi, H; Yoshioka, K | 1 |
| Abasov, IT | 1 |
| Kita, Y; Komi, N; Miyake, H; Nishi, M; Okada, A; Takehara, H; Yoshida, K | 1 |
| Gleissner, B; Haynes, H; Hilgenfeld, RU; Kaleya, R; Kreuser, ED; Rozenblit, A; Thiel, E; Wadler, S | 1 |
| Ardalan, B; Fleming, TR; Macdonald, JS; Martino, RL; Morrell, LM; Richman, SP | 1 |
| Brady, F; Brown, G; Harte, RJ; Jones, T; Luthra, SJ; Matthews, JC; O'Reilly, SM; Osman, S; Price, PM; Tilsley, DW | 1 |
| Hamaguchi, T; Hrushesky, WJ; Kakizoe, T; Kataoka, K; Kawaguchi, T; Matsumura, Y; Mizumura, Y; Moriyasu, F; Nishiyama, N | 1 |
| Goldberg, RM; Krook, JE; Kugler, JW; Laurie, JA; Moertel, CG; O'Connell, MJ; Pfeifle, DM; Rubin, J; Wieand, HS; Windschitl, HE | 1 |
| Bedikian, A; Benvenuto, JA; Bodey, GP; Chiuten, DF; Freireich, EJ; Loo, TL; Miller, A; Valdivieso, M | 1 |
| Daill, M; Fink, E; Kronberger, L; Schindler, R | 1 |
| Fink, E; Kronberger, L | 1 |
3 trial(s) available for aspartic acid and Cancer of Stomach
| Article | Year |
|---|---|
Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Phosphonoacetic Acid; Recombinant Proteins; Stomach Neoplasms | 1996 |
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Phosphonoacetic Acid; Stomach Neoplasms; Survival Rate | 1996 |
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.
Topics: Adult; Aged; Aspartic Acid; Clinical Trials as Topic; Colorectal Neoplasms; Drug Evaluation; Drug Synergism; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Phosphonoacetic Acid; Stomach Neoplasms; Thymidine | 1990 |
15 other study(ies) available for aspartic acid and Cancer of Stomach
| Article | Year |
|---|---|
The expression and clinical significance of the tRNA aspartic acid methyltransferase 1 protein in gastric cancer.
Topics: Aged; Aspartic Acid; Cell Line, Tumor; Cell Proliferation; Female; Humans; Male; Methyltransferases; Neoplasm Invasiveness; RNA, Transfer; Stomach Neoplasms | 2021 |
Multiple oxidative and advanced oxidative modifications of hemoglobin in gastric cancer patients measured by nanoflow LC-MS/MS.
Topics: Aspartic Acid; Biomarkers; Chromatography, Liquid; Hemoglobins; Histidine; Humans; Oxidative Stress; Peptides; Stomach Neoplasms; Tandem Mass Spectrometry; Tyrosine | 2022 |
Long noncoding RNA OVAAL enhances nucleotide synthesis through pyruvate carboxylase to promote 5-fluorouracil resistance in gastric cancer.
Topics: Aspartic Acid; Cell Line, Tumor; Drug Resistance, Neoplasm; Fluorouracil; Humans; Nucleotides; Oxaloacetates; Pyruvate Carboxylase; RNA, Long Noncoding; Stomach Neoplasms | 2022 |
Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
Topics: Alanine; Aspartic Acid; Glutamates; Humans; Immunotherapy; Metabolomics; Neoadjuvant Therapy; Proteomics; Receptor, ErbB-2; Stomach Neoplasms; Transcriptome; Tumor Microenvironment | 2022 |
Microbiota and metabolites alterations in proximal and distal gastric cancer patients.
Topics: Alanine; Arginine; Aspartic Acid; Feces; Glutamates; Hormones; Humans; Metabolomics; Microbiota; RNA, Ribosomal, 16S; Sphingolipids; Stomach Neoplasms | 2022 |
Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer.
Topics: Aspartic Acid; Biomarkers; Humans; Membrane Proteins; Mixed Function Oxygenases; Neoadjuvant Therapy; Oncogene Proteins; Prognosis; Stomach Neoplasms | 2023 |
Diffuse Leukoencephalopathy Associated with Dialysis Disequilibrium Syndrome.
Topics: Acidosis; Aspartic Acid; Coma; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Nausea; Renal Dialysis; Stomach Neoplasms; Treatment Outcome; Vomiting | 2015 |
Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Aspartic Acid; Caspase Inhibitors; Cell Line, Tumor; Cysteine Proteinase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Glycyrrhizic Acid; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Oligopeptides; Stomach Neoplasms; Time Factors | 2005 |
Chromatographic analysis of free amino acids of gastric juice in patients with cancer and other stomach diseases.
Topics: Adult; Alanine; Amino Acids; Arginine; Aspartic Acid; Chromatography; Cystine; Duodenal Ulcer; Female; Gastric Juice; Glutamates; Histidine; Humans; Leucine; Lysine; Male; Methionine; Ornithine; Phenylalanine; Polyps; Stomach Diseases; Stomach Neoplasms; Stomach Ulcer; Threonine; Tryptophan; Tyrosine; Valine | 1967 |
Increased aspartate and glutamate levels in both gastric and colon cancer tissues.
Topics: Aspartic Acid; Colonic Neoplasms; Gastric Mucosa; Glutamates; Glutamic Acid; Humans; Intestinal Mucosa; Protein Binding; Stomach Neoplasms | 1993 |
Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Area Under Curve; Aspartic Acid; Colorectal Neoplasms; Drug Interactions; Female; Fluorouracil; Humans; Interferon-alpha; Leucovorin; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasms; Phosphonoacetic Acid; Regional Blood Flow; Stomach Neoplasms; Tomography, Emission-Computed | 1999 |
Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity.
Topics: Animals; Aspartic Acid; Breast Neoplasms; Cell Survival; Cisplatin; Colonic Neoplasms; Drug Carriers; Female; Humans; Kidney; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Micelles; Polyethylene Glycols; Stomach Neoplasms; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Sequential administration of thymidine, 5-fluorouracil, and PALA. A phase I-II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Carcinoma, Bronchogenic; Chromatography, High Pressure Liquid; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Fluorouracil; Half-Life; Humans; Infusions, Parenteral; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Stomach Neoplasms; Thymidine | 1985 |
[Urinary excretion of asparagne and aspartate in control subjects and patients with cancer before and after treatment with K-Mg-aspartate].
Topics: Adolescent; Adult; Aged; Asparagine; Aspartic Acid; Breast Neoplasms; Cholecystitis; Female; Humans; Magnesium; Male; Middle Aged; Neoplasms; Potassium; Stomach Neoplasms | 1972 |
[Potassium-magnesium-aspartate therapy in operated cancer patients].
Topics: Adult; Aged; Anemia, Hypochromic; Aspartic Acid; Body Weight; Breast Neoplasms; Female; Hemoglobinometry; Humans; Ketoglutaric Acids; Long-Term Care; Magnesium; Male; Middle Aged; Ovarian Neoplasms; Postoperative Care; Potassium; Rectal Neoplasms; Rehabilitation; Retroperitoneal Neoplasms; Stomach Neoplasms; Thyroid Neoplasms; Tongue Neoplasms | 1971 |